Trends in antimalarial prescriptions in Australia 2002 to 2005

Journal of Travel Medicine

Volumn 15, Issue 5, 2008, Pages 302-306

  Leggat, Peter A ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DOXYCYCLINE; FANSIDAR; FOLIC ACID ANTAGONIST; HYDROXYCHLOROQUINE; MEFLOQUINE; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE; QUININE; QUININE BISULPHATE; QUININE SULFATE; UNCLASSIFIED DRUG;

ADVISORY COMMITTEE; ARTICLE; AUSTRALIA; CHEMOPROPHYLAXIS; CLINICAL PRACTICE; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG INDICATION; DRUG UTILIZATION; HEALTH CARE ORGANIZATION; HUMAN; MALARIA; MULTIDRUG RESISTANCE; PRACTICE GUIDELINE; PRESCRIPTION; TRAVEL;

ANTIMALARIALS; ARTEMISININS; ATOVAQUONE; AUSTRALIA; CHEMOPREVENTION; CHLOROGUANIDE; DOXYCYCLINE; ETHANOLAMINES; FLUORENES; HUMANS; MALARIA; MEFLOQUINE; PHYSICIAN-PATIENT RELATIONS; PRESCRIPTION DRUGS; PYRIMETHAMINE; RETROSPECTIVE STUDIES; TRAVEL;

EID: 53749089263     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2008.00227.x     Document Type: Article

References (27)

1. World Health Organization. Malaria. Fact sheet no. 94. Last updated May 2007. Available at : http://www.who.int/mediacentre/factsheets/fs094/en/index. html Accessed 2007 Dec 18)
2. Blumer C, Roche P, Spencer J, et al. Australia's notifiable disease status 2001: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2003 27 : 1 78.
3. Yohannes K, Roche P, Blumer C, et al. Australia's notifiable disease status 2002: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2004 28 : 6 68.
4. Miller P, Roche P, Yohannes K, et al. Australia's notifiable disease status 2003: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2005 29 : 1 61.
5. Yohannes K, Roche P, Roberts A, et al. Australia's notifiable disease status 2004: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2006 30 : 1 79.
6. Owen R, Roche P, Hope K, et al. Australia's notifiable disease status 2005: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2007 31 : 1 70.
7. Charles DM, Hart J, Davis WA, et al. Notifications of imported malaria in Western Australia, 1990-2001: incidence, associated factors and chemoprophylaxis. Med J Aust 2005 182 : 164 167.
8. Lewis SJ, Davidson RN, Ross EJ, Hall AP. Severity of imported malaria: effect of taking antimalarial prophylaxis. BMJ 1992 305 : 741 743.
9. Spicer J. Therapeutic guidelines: antibiotic. Version 11. North Melbourne : Therapeutic Guidelines Limited, 2000.
10. Spicer J. Therapeutic guidelines: antibiotic. Version 12. North Melbourne : Therapeutic Guidelines Limited, 2003.
11. McCall BJ, Pearce MC. Malaria treatment in Queensland, 1992. The use of malaria treatment guidelines. Med J Aust 1994 161 : 259 262.
12. Leggat PA, Speare R. Trends in antimalarial drugs prescribed in Australia, 1992-1998. J Travel Med 2003 10 : 189 191.
13. Leggat PA. Trends in antimalarial prescription in Australia 1998-2002. J Travel Med 2005 12 : 338 342.
14. Australian Bureau of Statistics. Australian resident departures. In : Year book Australia 2007. Catalogue No. 1301.0, 2007. Canberra : Australian Government. Available at : http://www.abs.gov.au/ausstats/abs@.nsf/ bb8db737e2af84b8ca2571780015701e/B45717BA3C781964CA25723600050EE4?opendocument Accessed 2007 Dec 18)
15. Pharmaceutical Benefits Advisory Committee, Drug Utilization Sub-Committee. Australian statistics on medicines 2001-2002. Canberra : Australian Government Publishing Service, 2004.
16. Pharmaceutical Benefits Advisory Committee, Drug Utilization Sub-Committee. Australian statistics on medicines 2003. Canberra : Commonwealth of Australia, 2005.
17. Pharmaceutical Benefits Advisory Committee, Drug Utilization Sub-Committee. Australian statistics on medicines 2004-2005. Canberra : Commonwealth of Australia, 2007.
18. Leggat PA, Heydon JL. Trends in antimalarial drugs prescribed in New Zealand 1993-1998. J Travel Med 2002 9 : 156 159.
19. Leggat PA, Dürrheim DN, Blumberg L. Trends in malaria chemoprophylaxis prescription in South Africa 1994-2000. J Travel Med 2002 9 : 318 321.
20. Van De Winkel K, Van den Daele A, Van Gompel A, Van den Ende J. Factors influencing standard pretravel health advice - a study in Belgium. J Travel Med 2007 14 : 288 296.
21. Ingram RJ, Ellis-Pegler RJ. Malaria, mefloquine and the mind. N Z Med J 1997 110 : 137 138.
22. World Health Organization. International travel and health. Geneva : WHO, 2007. Available at : http://www.who.int/ith Accessed 2007 Dec 18)
23. Kain KC. Prophylactic drugs for malaria: why do we need another one? J Travel Med 1999 6 (Suppl 1 S2 S7.
24. Edstein MD, Nasveld PE, Rieckmann KH. The challenge of effective chemoprophylaxis against malaria. ADF Health 2001 2 : 12 16.
25. Boggild AK, Parise ME, Lewis LS, Kain K. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg 2007 76 : 208 223.
26. World Health Organization. Guidelines for the treatment of malaria. Geneva : WHO, 2006. Available at : http://www.who.int/malaria/docs/ TreatmentGuidelines2006.pdf Accessed 2007 Dec 18)
27. Tekwani BL, Walker LA. 8-Aminoquinolines: future role as antiprotozoal drugs. Curr Opin Infect Dis 2006 19 : 623 631.